India's Food and Drug Administration FDA cancelled the plant's licence, effective 24 June, after 15 batches of baby powder products were found to have been sterilised by ethylene oxide, an irritant and cancer-causing component, through an unauthorised process.
Johnson Johnson did not respond to Campaign Asia-Pacific's requests for comment.
Peggy Ballman, a JJ spokeswoman, said in a statement that the company is currently working with Indian regulators to resolve the issue....
- Campaign Asia-Pacific online premium content* including in-depth monthly focus on key trends and industry issues
- Unlimited website access*, and an archive of more than 70,000 articles
- Regular value-added supplements including brand health checks, sector studies, ad critiques and research charts
- Daily newsletters and breaking story alerts straight to your inbox
- New weekly feature articles on the latest research, innovation and marketing trends
- Be the first to hear about industry events